Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 275

1.

Platelets Aggregate With Neutrophils and Promote Skin Pathology in Psoriasis.

Herster F, Bittner Z, Codrea MC, Archer NK, Heister M, Löffler MW, Heumos S, Wegner J, Businger R, Schindler M, Stegner D, Schäkel K, Grabbe S, Ghoreschi K, Miller LS, Weber ANR.

Front Immunol. 2019 Aug 16;10:1867. doi: 10.3389/fimmu.2019.01867. eCollection 2019.

2.

Using immuno-PET imaging to monitor kinetics of T cell-mediated inflammation and treatment efficiency in a humanized mouse model for GvHD.

Pektor S, Schlöder J, Klasen B, Bausbacher N, Wagner DC, Schreckenberger M, Grabbe S, Jonuleit H, Miederer M.

Eur J Nucl Med Mol Imaging. 2019 Aug 31. doi: 10.1007/s00259-019-04507-0. [Epub ahead of print]

PMID:
31471714
3.

RhoA as a Key Regulator of Innate and Adaptive Immunity.

Bros M, Haas K, Moll L, Grabbe S.

Cells. 2019 Jul 17;8(7). pii: E733. doi: 10.3390/cells8070733. Review.

4.

S1-Leitlinie Dermatofibrosarcoma protuberans (DFSP) - Update 2018.

Ugurel S, Kortmann RD, Mohr P, Mentzel T, Garbe C, Breuninger H, Bauer S, Grabbe S.

J Dtsch Dermatol Ges. 2019 Jun;17(6):663-668. doi: 10.1111/ddg.13849_g.

PMID:
31241846
5.

S2k-Leitlinie Merkelzellkarzinom (MZK, MCC, neuroendokrines Karzinom der Haut) - Update 2018.

Becker JC, Eigentler T, Frerich B, Gambichler T, Grabbe S, Höller U, Klumpp B, Loquai C, Krause-Bergmann A, Müller-Richter U, Pföhler C, Schneider-Burrus S, Stang A, Terheyden P, Ugurel S, Veith J, Mauch C.

J Dtsch Dermatol Ges. 2019 May;17(5):562-577. doi: 10.1111/ddg.13841_g.

PMID:
31115985
6.

S1 guidelines for dermatofibrosarcoma protuberans (DFSP) - update 2018.

Ugurel S, Kortmann RD, Mohr P, Mentzel T, Garbe C, Breuninger H, Bauer S, Grabbe S.

J Dtsch Dermatol Ges. 2019 Jun;17(6):663-668. doi: 10.1111/ddg.13849. Epub 2019 May 22.

PMID:
31115967
7.

S2k guidelines for Merkel cell carcinoma (MCC, neuroendocrine carcinoma of the skin) - update 2018.

Becker JC, Eigentler T, Frerich B, Gambichler T, Grabbe S, Höller U, Klumpp B, Loquai C, Krause-Bergmann A, Müller-Richter U, Pföhler C, Schneider-Burrus S, Stang A, Terheyden P, Ugurel S, Veith J, Mauch C.

J Dtsch Dermatol Ges. 2019 May;17(5):562-576. doi: 10.1111/ddg.13841. Epub 2019 May 6.

PMID:
31056838
8.

Effective treatment of disseminated superficial actinic porokeratosis with chemical peels - customary treatment for a rare disease.

Lang BM, Peveling-Oberhag A, Zimmer S, Wegner J, Sohn A, Grabbe S, Staubach P.

J Dermatolog Treat. 2019 Apr 25:1-17. doi: 10.1080/09546634.2019.1610551. [Epub ahead of print]

PMID:
31018713
9.

[The "light" version of a perforator flap: significance of the Keystone Designed Perforator Flap Concept (KDPFC) in the lower extremity].

Schepler H, Sauerbier M, Grabbe S, Rietz S.

Handchir Mikrochir Plast Chir. 2019 Aug;51(4):232-237. doi: 10.1055/a-0839-4974. Epub 2019 Apr 8. German.

PMID:
30959534
10.

Sodium chloride is an ionic checkpoint for human TH2 cells and shapes the atopic skin microenvironment.

Matthias J, Maul J, Noster R, Meinl H, Chao YY, Gerstenberg H, Jeschke F, Gasparoni G, Welle A, Walter J, Nordström K, Eberhardt K, Renisch D, Donakonda S, Knolle P, Soll D, Grabbe S, Garzorz-Stark N, Eyerich K, Biedermann T, Baumjohann D, Zielinski CE.

Sci Transl Med. 2019 Feb 20;11(480). pii: eaau0683. doi: 10.1126/scitranslmed.aau0683.

PMID:
30787167
11.

CD11b Regulates Fungal Outgrowth but Not Neutrophil Recruitment in a Mouse Model of Invasive Pulmonary Aspergillosis.

Teschner D, Cholaszczyńska A, Ries F, Beckert H, Theobald M, Grabbe S, Radsak M, Bros M.

Front Immunol. 2019 Feb 4;10:123. doi: 10.3389/fimmu.2019.00123. eCollection 2019.

12.

S2k Guidelines for Cutaneous Basal Cell Carcinoma - Part 2: Treatment, Prevention and Follow-up.

Lang BM, Balermpas P, Bauer A, Blum A, Brölsch GF, Dirschka T, Follmann M, Frank J, Frerich B, Fritz K, Hauschild A, Heindl LM, Howaldt HP, Ihrler S, Kakkassery V, Klumpp B, Krause-Bergmann A, Löser C, Meissner M, Sachse MM, Schlaak M, Schön MP, Tischendorf L, Tronnier M, Vordermark D, Welzel J, Weichenthal M, Wiegand S, Kaufmann R, Grabbe S.

J Dtsch Dermatol Ges. 2019 Feb;17(2):214-230. doi: 10.1111/ddg.13755.

PMID:
30762963
13.

S2k-Leitlinie Basalzellkarzinom der Haut - Teil 2: Therapie, Prävention und Nachsorge.

Lang BM, Balermpas P, Bauer A, Blum A, Brölsch GF, Dirschka T, Follmann M, Frank J, Frerich B, Fritz K, Hauschild A, Heindl LM, Howaldt HP, Ihrler S, Kakkassery V, Klumpp B, Krause-Bergmann A, Löser C, Meissner M, Sachse MM, Schlaak M, Schön MP, Tischendorf L, Tronnier M, Vordermark D, Welzel J, Weichenthal M, Wiegand S, Kaufmann R, Grabbe S.

J Dtsch Dermatol Ges. 2019 Feb;17(2):214-231. doi: 10.1111/ddg.13755_g. No abstract available.

PMID:
30762951
14.

IgE-specific immunoadsorption: New treatment option for severe refractory atopic dermatitis.

Wegner J, Saloga J, Grabbe S, Wilden S, Vewinger N, Lutz J, Weinmann-Menke J, von Stebut E.

Allergy. 2019 Jun;74(6):1190-1193. doi: 10.1111/all.13716. Epub 2019 Feb 5. No abstract available.

PMID:
30636038
15.

S2k-Leitlinie Basalzellkarzinom der Haut - Teil 1: Epidemiologie, Genetik und Diagnostik.

Lang BM, Balermpas P, Bauer A, Blum A, Brölsch GF, Dirschka T, Follmann M, Frank J, Frerich B, Fritz K, Hauschild A, Heindl LM, Howaldt HP, Ihrler S, Kakkassery V, Klumpp B, Krause-Bergmann A, Löser C, Meissner M, Sachse MM, Schlaak M, Schön MP, Tischendorf L, Tronnier M, Vordermark D, Welzel J, Weichenthal M, Wiegand S, Kaufmann R, Grabbe S.

J Dtsch Dermatol Ges. 2019 Jan;17(1):94-104. doi: 10.1111/ddg.13733_g. No abstract available.

PMID:
30615280
16.

S2k Guidelines for Cutaneous Basal Cell Carcinoma - Part 1: Epidemiology, Genetics and Diagnosis.

Lang BM, Balermpas P, Bauer A, Blum A, Brölsch GF, Dirschka T, Follmann M, Frank J, Frerich B, Fritz K, Hauschild A, Heindl LM, Howaldt HP, Ihrler S, Kakkassery V, Klumpp B, Krause-Bergmann A, Löser C, Meissner M, Sachse MM, Schlaak M, Schön MP, Tischendorf L, Tronnier M, Vordermark D, Welzel J, Weichenthal M, Wiegand S, Kaufmann R, Grabbe S.

J Dtsch Dermatol Ges. 2019 Jan;17(1):94-103. doi: 10.1111/ddg.13733. Epub 2018 Dec 28. Review.

PMID:
30592557
17.

Long-term survival of patients after ipilimumab and hypofractionated brain radiotherapy for brain metastases of malignant melanoma: sequence matters.

Schmidberger H, Rapp M, Ebersberger A, Hey-Koch S, Loquai C, Grabbe S, Mayer A.

Strahlenther Onkol. 2018 Dec;194(12):1144-1151. doi: 10.1007/s00066-018-1356-5. Epub 2018 Oct 8.

18.

Delivering all in one: Antigen-nanocapsule loaded with dual adjuvant yields superadditive effects by DC-directed T cell stimulation.

Paßlick D, Piradashvili K, Bamberger D, Li M, Jiang S, Strand D, R Wich P, Landfester K, Bros M, Grabbe S, Mailänder V.

J Control Release. 2018 Nov 10;289:23-34. doi: 10.1016/j.jconrel.2018.09.008. Epub 2018 Sep 13.

PMID:
30219277
19.

The Protein Corona as a Confounding Variable of Nanoparticle-Mediated Targeted Vaccine Delivery.

Bros M, Nuhn L, Simon J, Moll L, Mailänder V, Landfester K, Grabbe S.

Front Immunol. 2018 Aug 2;9:1760. doi: 10.3389/fimmu.2018.01760. eCollection 2018. Review.

20.

Alterations in Titin Properties and Myocardial Fibrosis Correlate With Clinical Phenotypes in Hemodynamic Subgroups of Severe Aortic Stenosis.

Gotzmann M, Grabbe S, Schöne D, von Frieling-Salewsky M, Dos Remedios CG, Strauch J, Bechtel M, Dietrich JW, Tannapfel A, Mügge A, Linke WA.

JACC Basic Transl Sci. 2018 Jun 25;3(3):335-346. doi: 10.1016/j.jacbts.2018.02.002. eCollection 2018 Jun.

21.

Interleukin-1 Beta-A Friend or Foe in Malignancies?

Bent R, Moll L, Grabbe S, Bros M.

Int J Mol Sci. 2018 Jul 24;19(8). pii: E2155. doi: 10.3390/ijms19082155. Review.

22.

BRAF inhibitors stimulate inflammasome activation and interleukin 1 beta production in dendritic cells.

Hajek E, Krebs F, Bent R, Haas K, Bast A, Steinmetz I, Tuettenberg A, Grabbe S, Bros M.

Oncotarget. 2018 Jun 19;9(47):28294-28308. doi: 10.18632/oncotarget.25511. eCollection 2018 Jun 19.

23.

Sentinel lymph node biopsy in malignant melanoma of the head and neck.

Rahimi-Nedjat RK, Al-Nawas B, Tuettenberg A, Sagheb K, Grabbe S, Walter C.

J Craniomaxillofac Surg. 2018 Jun;46(6):1027-1031. doi: 10.1016/j.jcms.2018.04.011. Epub 2018 Apr 12.

PMID:
29735384
24.

Checkpoint-Inhibitor nun auch zur Therapie des metastasierten Merkelzellkarzinoms zugelassen.

Grabbe S, Terheyden P, Becker JC.

J Dtsch Dermatol Ges. 2018 Mar;16(3):394-395. doi: 10.1111/ddg.13432. No abstract available.

PMID:
29537164
25.

Clinical outcome of concomitant vs interrupted BRAF inhibitor therapy during radiotherapy in melanoma patients.

Hecht M, Meier F, Zimmer L, Polat B, Loquai C, Weishaupt C, Forschner A, Gutzmer R, Utikal JS, Goldinger SM, Geier M, Hassel JC, Balermpas P, Kiecker F, Rauschenberg R, Dietrich U, Clemens P, Berking C, Grabenbauer G, Schadendorf D, Grabbe S, Schuler G, Fietkau R, Distel LV, Heinzerling L.

Br J Cancer. 2018 Mar 20;118(6):785-792. doi: 10.1038/bjc.2017.489. Epub 2018 Feb 13.

26.

Friend virus limits adaptive cellular immune responses by imprinting a maturation-resistant and T helper type 2-biased immunophenotype in dendritic cells.

Shen L, Tenzer S, Hess M, Distler U, Tubbe I, Montermann E, Schimmer S, Dittmer U, Grabbe S, Bros M.

PLoS One. 2018 Feb 9;13(2):e0192541. doi: 10.1371/journal.pone.0192541. eCollection 2018.

27.

Long-term survival with modern therapeutic agents against metastatic melanoma-vemurafenib and ipilimumab in a daily life setting.

Lang BM, Peveling-Oberhag A, Faidt D, Hötker AM, Weyer-Elberich V, Grabbe S, Loquai C.

Med Oncol. 2018 Jan 31;35(3):24. doi: 10.1007/s12032-018-1084-9.

PMID:
29387968
28.

Protein corona-mediated targeting of nanocarriers to B cells allows redirection of allergic immune responses.

Shen L, Tenzer S, Storck W, Hobernik D, Raker VK, Fischer K, Decker S, Dzionek A, Krauthäuser S, Diken M, Nikolaev A, Maxeiner J, Schuster P, Kappel C, Verschoor A, Schild H, Grabbe S, Bros M.

J Allergy Clin Immunol. 2018 Nov;142(5):1558-1570. doi: 10.1016/j.jaci.2017.08.049. Epub 2018 Jan 31.

29.

S2k-Leitlinie - Kutane Lymphome Update 2016 - Teil 2: Therapie und Nachsorge (ICD10 C82 - C86).

Dippel E, Assaf C, Becker JC, von Bergwelt-Baildon M, Beyer M, Cozzio A, Eich HT, Follmann M, Grabbe S, Hillen U, Klapper W, Klemke CD, Lamos C, Loquai C, Meiß F, Mestel D, Nashan D, Nicolay JP, Oschlies I, Schlaak M, Stoll C, Vag T, Weichenthal M, Wobser M, Stadler R.

J Dtsch Dermatol Ges. 2018 Jan;16(1):112-123. doi: 10.1111/ddg.13401_g. No abstract available.

PMID:
29314698
30.

S2k Guidelines - Cutaneous Lymphomas Update 2016 - Part 2: Treatment and Follow-up (ICD10 C82 - C86).

Dippel E, Assaf C, Becker JC, von Bergwelt-Baildon M, Beyer M, Cozzio A, Eich HT, Follmann M, Grabbe S, Hillen U, Klapper W, Klemke CD, Lamos C, Loquai C, Meiß F, Mestel D, Nashan D, Nicolay JP, Oschlies I, Schlaak M, Stoll C, Vag T, Weichenthal M, Wobser M, Stadler R.

J Dtsch Dermatol Ges. 2018 Jan;16(1):112-122. doi: 10.1111/ddg.13401. Epub 2017 Dec 27. No abstract available.

PMID:
29280595
31.

Shifting cancer care towards Multidisciplinarity: the cancer center certification program of the German cancer society.

Kowalski C, Graeven U, von Kalle C, Lang H, Beckmann MW, Blohmer JU, Burchardt M, Ehrenfeld M, Fichtner J, Grabbe S, Hoffmann H, Iro H, Post S, Scharl A, Schlegel U, Seufferlein T, Stummer W, Ukena D, Ferencz J, Wesselmann S.

BMC Cancer. 2017 Dec 14;17(1):850. doi: 10.1186/s12885-017-3824-1.

32.

S2k-Leitlinie - Kutane Lymphome Update 2016 - Teil 1: Klassifikation und Diagnostik (ICD10 C82 - C86).

Dippel E, Assaf C, Becker JC, von Bergwelt-Baildon M, Beyer M, Cozzio A, Eich HT, Follmann M, Grabbe S, Hillen U, Klapper W, Klemke CD, Lamos C, Loquai C, Meiß F, Mestel D, Nashan D, Nicolay JP, Oschlies I, Schlaak M, Stoll C, Vag T, Weichenthal M, Wobser M, Stadler R.

J Dtsch Dermatol Ges. 2017 Dec;15(12):1266-1273. doi: 10.1111/ddg.13372_g. No abstract available.

PMID:
29228489
33.

S2k Guidelines - Cutaneous Lymphomas Update 2016 - Part 1: Classification and Diagnosis (ICD10 C82 - C86).

Dippel E, Assaf C, Becker JC, von Bergwelt-Baildon M, Beyer M, Cozzio A, Eich HT, Follmann M, Grabbe S, Hillen U, Klapper W, Klemke CD, Lamos C, Loquai C, Meiß F, Mestel D, Nashan D, Nicolay JP, Oschlies I, Schlaak M, Stoll C, Vag T, Weichenthal M, Wobser M, Stadler R.

J Dtsch Dermatol Ges. 2017 Dec;15(12):1266-1273. doi: 10.1111/ddg.13372. Epub 2017 Nov 28. No abstract available.

PMID:
29193659
34.

[WHO classification and clinical spectrum of cutaneous lymphomas].

Mitteldorf C, Grabbe S, Stadler R.

Hautarzt. 2017 Sep;68(9):682-695. doi: 10.1007/s00105-017-4025-1. Review. German.

PMID:
28831508
35.

[Importance of cutaneous lymphomas in clinical practice].

Klemke CD, Hillen U, Grabbe S.

Hautarzt. 2017 Sep;68(9):680-681. doi: 10.1007/s00105-017-4026-0. German. No abstract available.

PMID:
28770284
36.

PeptoSomes for Vaccination: Combining Antigen and Adjuvant in Polypept(o)ide-Based Polymersomes.

Weber B, Kappel C, Scherer M, Helm M, Bros M, Grabbe S, Barz M.

Macromol Biosci. 2017 Oct;17(10). doi: 10.1002/mabi.201700061. Epub 2017 Jul 31.

PMID:
28759159
37.

Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer.

Sahin U, Derhovanessian E, Miller M, Kloke BP, Simon P, Löwer M, Bukur V, Tadmor AD, Luxemburger U, Schrörs B, Omokoko T, Vormehr M, Albrecht C, Paruzynski A, Kuhn AN, Buck J, Heesch S, Schreeb KH, Müller F, Ortseifer I, Vogler I, Godehardt E, Attig S, Rae R, Breitkreuz A, Tolliver C, Suchan M, Martic G, Hohberger A, Sorn P, Diekmann J, Ciesla J, Waksmann O, Brück AK, Witt M, Zillgen M, Rothermel A, Kasemann B, Langer D, Bolte S, Diken M, Kreiter S, Nemecek R, Gebhardt C, Grabbe S, Höller C, Utikal J, Huber C, Loquai C, Türeci Ö.

Nature. 2017 Jul 13;547(7662):222-226. doi: 10.1038/nature23003. Epub 2017 Jul 5.

PMID:
28678784
38.

Pembrolizumab-induzierter Lichen planus pemphigoides bei einem Patienten mit metastasiertem Melanom.

Schmidgen MI, Butsch F, Schadmand-Fischer S, Steinbrink K, Grabbe S, Weidenthaler-Barth B, Loquai C.

J Dtsch Dermatol Ges. 2017 Jul;15(7):742-745. doi: 10.1111/ddg.13272_g. No abstract available.

PMID:
28677196
39.

Pembrolizumab-induced lichen planus pemphigoides in a patient with metastatic melanoma.

Schmidgen MI, Butsch F, Schadmand-Fischer S, Steinbrink K, Grabbe S, Weidenthaler-Barth B, Loquai C.

J Dtsch Dermatol Ges. 2017 Jul;15(7):742-745. doi: 10.1111/ddg.13272. Epub 2017 Jun 16. No abstract available.

PMID:
28622432
40.

Role of Protein Kinase C and Nox2-Derived Reactive Oxygen Species Formation in the Activation and Maturation of Dendritic Cells by Phorbol Ester and Lipopolysaccharide.

Stein J, Steven S, Bros M, Sudowe S, Hausding M, Oelze M, Münzel T, Grabbe S, Reske-Kunz A, Daiber A.

Oxid Med Cell Longev. 2017;2017:4157213. doi: 10.1155/2017/4157213. Epub 2017 Mar 28.

41.

Asymptomatische, erworbene symmetrische Läsionen am Augeninnenwinkel.

Wilden S, Lang B, Weidenthaler-Barth B, Grabbe S, Tuettenberg A.

J Dtsch Dermatol Ges. 2017 Mar;15(3):842-844. doi: 10.1111/ddg.13068_g. No abstract available.

PMID:
28252866
42.

Acquired symmetric asymptomatic lesions at the inner corners of the eyes.

Wilden S, Lang B, Weidenthaler-Barth B, Grabbe S, Tuettenberg A.

J Dtsch Dermatol Ges. 2017 Mar;15(3):342-344. doi: 10.1111/ddg.13068. No abstract available.

PMID:
28252865
43.

Zwei Brüder mit Papillomatosis confluens et reticularis.

Rietz S, Grabbe S, von Stebut E.

J Dtsch Dermatol Ges. 2016 Dec;14(12):1302-1304. doi: 10.1111/ddg.12982_g. No abstract available.

PMID:
27992135
44.

Two brothers with confluent and reticulated papillomatosis.

Rietz S, Grabbe S, von Stebut E.

J Dtsch Dermatol Ges. 2016 Dec;14(12):1303-1305. doi: 10.1111/ddg.12982. No abstract available.

PMID:
27992124
45.

New-onset third-degree atrioventricular block because of autoimmune-induced myositis under treatment with anti-programmed cell death-1 (nivolumab) for metastatic melanoma.

Behling J, Kaes J, Münzel T, Grabbe S, Loquai C.

Melanoma Res. 2017 Apr;27(2):155-158. doi: 10.1097/CMR.0000000000000314.

PMID:
27977496
46.

ADF Winter School-An exciting concept of the Arbeitsgemeinschaft Dermatologische Forschung to connect young scientists and clinician scientists in Dermatology at the top of Germany.

Yazdi AS, Barlin M, Böhm K, Gendrisch F, Ghorbanalipoor S, Häberle S, Hamel A, Hüning S, Hüttner C, Iwanova I, Kanaki T, Kimeswenger S, Lohmann N, Munir S, Muzumdar S, Pereira MP, Peking P, Plesser K, Rendon A, Rentschler M, Schlumprecht C, Smorodchenko A, Stock M, Tillmanns J, Uslu U, Ghoreschi K, Glatz M, Grabbe S, Kunz M, Ludwig R, Scharffetter-Kochanek K, Loser K.

Exp Dermatol. 2017 Mar;26(3):292-294. doi: 10.1111/exd.13241. Epub 2016 Nov 3. No abstract available.

PMID:
27808431
47.

Toll like receptor mediated immune stimulation can be visualized in vivo by [18F]FDG-PET.

Pektor S, Bausbacher N, Otto G, Lawaczeck L, Grabbe S, Schreckenberger M, Miederer M.

Nucl Med Biol. 2016 Nov;43(11):651-660. doi: 10.1016/j.nucmedbio.2016.07.004. Epub 2016 Jul 14.

PMID:
27552488
48.

Past, present and future of immunology in Mainz.

Waisman A, Hövelmeyer N, Diefenbach A, Schuppan D, Reddehase MJ, Kleinert H, Kaina B, Grabbe S, Galle PR, Theobald M, Zipp F, Sahin U, Türeci Ö, Kreiter S, Langguth P, Decker H, van Zandbergen G, Schild H.

Cell Immunol. 2016 Oct;308:1-6. doi: 10.1016/j.cellimm.2016.09.001. No abstract available.

PMID:
27719802
49.

Translating nanoparticulate-personalized cancer vaccines into clinical applications: case study with RNA-lipoplexes for the treatment of melanoma.

Grabbe S, Haas H, Diken M, Kranz LM, Langguth P, Sahin U.

Nanomedicine (Lond). 2016 Oct;11(20):2723-2734. Review.

PMID:
27700619
50.

Nanoparticles and the immune system: challenges and opportunities.

Grabbe S, Landfester K, Schuppan D, Barz M, Zentel R.

Nanomedicine (Lond). 2016 Oct;11(20):2621-2624. Epub 2016 Sep 20. No abstract available.

Supplemental Content

Loading ...
Support Center